
Advances in CAR-T and cellular therapy from EBMT 2020: MSCs, clinical trial updates and gene-edited effector cells
VJHemOnc Podcast
CAR-T Cell Therapy in Difficult-to-Treat Patient Populations
This chapter explores the treatment outcomes of CAR-T cell therapy in a challenging patient population, highlighting promising results from the carmar trial and another CAR-T cell trial for multiple myeloma. It also discusses key clinical trials for refractory-diffuse large B-cell lymphoma.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.